Back
Zevra Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
ZVRA
Zevra Therapeutics
Last Price:
$12.66
Seasonality Move:
11.56%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing selling pressure, which indicates risk of future bearish movement.
Zevra Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.1 | Buy |
20-day SMA: | 10.32 | Buy |
50-day SMA: | 9.26 | Buy |
200-day SMA: | 8.36 | Buy |
8-day EMA: | 10.25 | Buy |
20-day EMA: | 6.19 | Buy |
50-day EMA: | 2.99 | Buy |
200-day EMA: | 0.83 | Buy |
Zevra Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.39 | Buy |
Relative Strength Index (14 RSI): | 75.77 | Buy |
Chaikin Money Flow: | -936809 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.69 - 11.53) | Buy |
Bollinger Bands (100): | (7.07 - 9.73) | Buy |
Zevra Therapeutics Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Zevra Therapeutics Stock
Is Zevra Therapeutics Stock a Buy?
-
Zevra Therapeutics share price is 12.32 while ZVRA 8-day simple moving average is 12.10, which is a Buy signal.
-
The stock price of ZVRA is 12.32 while Zevra Therapeutics 20-day SMA is 10.32, which makes it a Buy.
-
Zevra Therapeutics 50-day simple moving average is 9.26 while ZVRA share price is 12.32, making it a Buy technically.
-
ZVRA stock price is 12.32 and Zevra Therapeutics 200-day simple moving average is 8.36, creating a Buy signal.
ZVRA Technical Analysis vs Fundamental Analysis
Buy
56
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy or a Sell?
-
Zevra Therapeutics stock is rated a BuyThe current Zevra Therapeutics [ZVRA] share price is $12.32. The Score for ZVRA is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Zevra Therapeutics Stock Info
Market Cap:
673.7M
Price in USD:
12.32
Share Volume:
1.6M
Zevra Therapeutics 52-Week Range
52-Week High:
13.16
52-Week Low:
5.45
Buy
56
Zevra Therapeutics (ZVRA)
is a Buy
Zevra Therapeutics Share Price Forecast
-
What is the Zevra Therapeutics stock price today?The Zevra Therapeutics stock price is 12.32 USD today.
-
Will ZVRA stock go up or go down?Zevra Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Zevra Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics is not overvalued.
Is Zevra Therapeutics Stock a Buy?
-
Zevra Therapeutics share price is 12.32 while ZVRA 8-day exponential moving average is 10.25, which is a Buy signal.
-
The stock price of ZVRA is 12.32 while Zevra Therapeutics 20-day EMA is 6.19, which makes it a Buy.
-
Zevra Therapeutics 50-day exponential moving average is 2.99 while ZVRA share price is 12.32, making it a Buy technically.
-
ZVRA stock price is 12.32 and Zevra Therapeutics 200-day simple moving average is 0.83, creating a Buy signal.
Fundamental Analysis of Zevra Therapeutics
Is Zevra Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.23 per share, an increase this year of $3.37 per share, and a decrease next year of $0.81 per share.
Technical Analysis of Zevra Therapeutics
Should I short Zevra Therapeutics stock?
-
ZVRA Moving Average Covergence Divergence (MACD) indicator is 3.39, suggesting Zevra Therapeutics is a Buy
-
Zevra Therapeutics Relative Strength Index (RSI) is 75.77, which suggest Zevra Therapeutics is overbought
-
The Bollinger Bands (25) for Zevra Therapeutics is (8.69 - 11.53), which suggest Zevra Therapeutics is a Buy
-
The Bollinger Bands (100) for Zevra Therapeutics is (7.07 - 9.73), which suggest Zevra Therapeutics is a Buy
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.